Pre-Treatment With Oral P2Y₁₂ Inhibitors in Acute Coronary Syndromes Without ST-Segment Elevation: The Saga Continues

Affiliations

¹ Division of Cardiology, C.A.S.T., P.O. "G. Rodolico," Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele," University of Catania, Catania, Italy. Electronic address: dcapodanno@gmail.com.
² University of Florida, College of Medicine, Jacksonville, Florida.

Free article

Editorial

Davide Capodanno et al. J Am Coll Cardiol. 2019.

Free article

. 2019 Mar 5;73(8):915-918.

doi: 10.1016/j.jacc.2018.12.038.

¹ Division of Cardiology, C.A.S.T., P.O. "G. Rodolico," Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele," University of Catania, Catania, Italy. Electronic address: dcapodanno@gmail.com.
² University of Florida, College of Medicine, Jacksonville, Florida.

No abstract available

Keywords: acute coronary syndrome; clopidogrel; myocardial infarction; percutaneous coronary intervention; prasugrel; pre-treatment; ticagrelor.

Comment on

Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non-ST-Segment Elevation Myocardial Infarction.
Silvain J, Rakowski T, Lattuca B, Liu Z, Bolognese L, Goldstein P, Hamm C, Tanguay JF, Ten Berg J, Widimsky P, Miller D, Portal JJ, Collet JP, Vicaut E, Montalescot G, Dudek D; ACCOAST Investigators. Silvain J, et al. J Am Coll Cardiol. 2019 Mar 5;73(8):906-914. doi: 10.1016/j.jacc.2018.11.055. J Am Coll Cardiol. 2019. PMID: 30819358 Clinical Trial.